Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2824]

ESMO 2025: Research targets treatment resistance in neuroendocrine tumours

ESMO 2025: Research targets treatment resistance in neuroendocrine tumours

ESMO 2025: ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

ESMO 2025: ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for...

ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease

ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease

ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC

ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC

Study reveals how bacteria in tumours drive treatment resistance in cancer

Study reveals how bacteria in tumours drive treatment resistance in cancer

Study finds restoring order to dividing cancer cells may prevent metastasis

Study finds restoring order to dividing cancer cells may prevent metastasis

Uncovering EUDAL – An RNA that shields oral cancer from drug therapy

Uncovering EUDAL – An RNA that shields oral cancer from drug therapy

Researchers show novel immune system boost helps fight cancer cells

Researchers show novel immune system boost helps fight cancer cells

ASTRO 2025: Pulsed low dose rate chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with oesophageal cancer and non-small cell lung cancer

ASTRO 2025: Pulsed low dose rate chemoradiation therapy can significantly reduce side effects while maintaining...

New insight into the response mechanism of arsenic in treating acute promyelocytic leukaemia

New insight into the response mechanism of arsenic in treating acute promyelocytic leukaemia

More from ecancer